Current trends in the monitoring and treatment of diabetic retinopathy in young adults

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Raczyńska, Dorota ^a   Zorena, Katarzyna ^b   Urban, Beata ^c   Zalewski, Dominik ^d   Skorek, Andrzej ^a   Malukiewicz, Grazyna ^e   Sikorski, Bartosz L ^e  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d Diagnostic and Microsurgery Center of the Eye Lens   (Poland)

^e NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; CORTICOSTEROID; VASCULOTROPIN INHIBITOR; INSULIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTERIAL PRESSURE; BIBLIOGRAPHIC DATABASE; BLOOD CLOTTING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHILDHOOD OBESITY; COMPARATIVE STUDY; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DISORDERS OF LIPID METABOLISM; DNA POLYMORPHISM; DRUG INDUSTRY; ELECTRORETINOGRAM; ENDOTHELIAL DYSFUNCTION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LASER COAGULATION; LOW LEVEL LASER THERAPY; METABOLIC REGULATION; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL TOMOGRAPHY; PATHOGENESIS; PATIENT MONITORING; PHOTOGRAPHY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUBERTY; RETINAL THICKNESS; REVIEW; RISK FACTOR; SCREENING; SMOKING; TOMOGRAPHY; VISUAL ACUITY; COMPLICATION; DIABETES MELLITUS, TYPE 1; INFLAMMATION; LIPID METABOLISM; METABOLISM; OBESITY; YOUNG ADULT;

ADIPONECTIN; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN; LIPID METABOLISM; OBESITY; PREVALENCE; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84896273627     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/492926     Document Type: Review

References (124)

1. Amos A. F., McCarty D. J., Zimmet P., The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine 1997 14 supplement 5 S7 S85 2-s2.0-0031445908 (Pubitemid 28020378)
2. Silink M., Childhood diabetes: a global perspective. Hormone Research 2002 57 1 1 5 2-s2.0-0036234881 (Pubitemid 34458073)
3. International Diabetes Federation (IDF) Diabetes Atlas 2007. http://www.eatlas.idf.org/
4. Hamasaki H., Moriyama S., Yanai H., A crosstalk between macroangiopathy and microangiopathy in type 2 diabetes. International Journal of Cardiology 2013 168 1 550 551
5. Bunce C., Wormald R., Causes of blind certifications in England and Wales: April 1999-March 2000. Eye 2008 22 7 905 911 2-s2.0-48049095176 10.1038/sj.eye.6702767
6. Resnikoff S., Keys T. U., Future trends in global blindness. Indian Journal of Ophthalmology 2012 60 5 387 395
7. Centers for Disease Control and Prevention (CDC), Self-reported visual impairment among persons with diagnosed diabetes-United States, 1997-2010. Morbidity and Mortality Weekly Report 2011 60 45 1549 1553
8. Chakrabarti R., Harper C. A., Keeffe J. E., Diabetic retinopathy management guidelines. Expert Review of Ophthalmology 2012 7 5 417 439
9. Downie E., Craig M. E., Hing S., Cusumano J., Chan A. K. F., Donaghue K. C., Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care 2011 34 11 2368 2373 2-s2.0-84857066780
10. Lecaire T., Palta M., Zhang H., Allen C., Klein R., D'Alessio D., Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study. American Journal of Epidemiology 2006 164 2 143 150 2-s2.0-33745591100 10.1093/aje/kwj166 (Pubitemid 43992180)
11. Klein R., Klein B. E. K., Moss S. E., Davis M. D., DeMets D. L., The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology 1984 102 4 520 526 2-s2.0-0021136256 (Pubitemid 14127838)
12. Skrivarhaug T., Fosmark D. S., Stene L. C., Bangstad H.-J., Sandvik L., Hanssen K. F., Joner G., Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia 2006 49 10 2281 2290 2-s2.0-33748511422 10.1007/s00125-006-0364-7 (Pubitemid 44359088)
13. Klein R., Knudtson M. D., Lee K. E., Gangnon R., Klein B. E. K., The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009 116 3 497 503 2-s2.0-61349121337 10.1016/j.ophtha.2008.10.016
14. Simsek D. G., Aycan Z., Özen S., Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. Journal of Clinical Research in Pediatric Endocrinology 2013 5 1 20 26
15. Urban B., Raczyńska D., Bakunowicz-Lazarczyk A., Raczyńska K., Krȩtowska M., Evaluation of corneal endothelium in children and adolescents with type 1 diabetes mellitus. Mediators of Inflammation 2013 2013 6 10.1155/2013/913754 913754
16. Kubin M., Tossavainen P., Hannula V., Lahti S., Hautala N., Falck A., Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study. Archives of Disease in Childhood 2011 96 10 963 968 2-s2.0-80052835057 10.1136/adc.2011. 210807
17. Klein R., Klein B. E. K., Moss S. E., Davis M. D., DeMets D. L., The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology 1989 107 2 237 243 2-s2.0-0024537989 (Pubitemid 19055344)
18. Zorena K., Kula M., Malinowska E., Raczyńska D., Myśliwiec M., Raczyńska K., Threshold serum concentrations of tumour necrosis factor alpha (TNF) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM). Human Immunology 2013 74 1 75 81
19. Kaidonis G., Abhary S., Daniell M., Gillies M., Fogarty R., Petrovsky N., Jenkins A., Essex R., Chang J. H., Pal B., Hewitt A. W., Burdon K. P., Craig J. E., Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics. Clinical & Experimental Ophthalmology 2013 10.1111/ceo.12239
20. Falck A. A. K., Knip J. M., Ilonen J. S., Laatikainen L. T., Genetic markers in early diabetic retinopathy of adolescents with type I diabetes. Journal of Diabetes and Its Complications 1997 11 4 203 207 2-s2.0-0030990454 10.1016/S1056-8727(96)00051-7 (Pubitemid 27271901)
21. Hofer S. E., Bennetts B., Chan A. K., Holloway B., Karschimkus C., Jenkins A. J., Silink M., Donaghue K. C., Association between PON 1 polymorphisms, PON activity and diabetes complications. Journal of Diabetes and Its Complications 2006 20 5 322 328 2-s2.0-33747884508 10.1016/j.jdiacomp.2005. 08.008 (Pubitemid 44292534)
22. Wiltshire E. J., Mohsin F., Chan A., Donaghue K. C., Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes. Pediatric Diabetes 2008 9 4 348 353 2-s2.0-48649109301 10.1111/j.1399-5448.2008.00374.x
23. Mamoulakis D., Bitsori M., Galanakis E., Vazgiourakis V., Panierakis C., Goulielmos G. N., Intron 4 polymorphism of the endothelial nitric oxide synthase eNOS gene and early microangiopathy in type 1 diabetes. International Journal of Immunogenetics 2009 36 3 153 157 2-s2.0-65649112442 10.1111/j.1744-313X.2009. 00839.x
24. Ray D., Mishra M., Ralph S., Read I., Davies R., Brenchley P., Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004 53 3 861 864 2-s2.0-1442349965 10.2337/diabetes.53.3.861 (Pubitemid 38270661)
25. Beránek M., Kanková K., Benes P., Izakovicová- Hollá L., Znojil V., Hájek D., Vlková E., Vácha J., Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF- β 1) is a newly identified risk factor for proliferative diabetic retinopathy. American Journal of Medical Genetics 2002 109 4 278 283
26. Donaghue K. C., Chiarelli F., Trotta D., Allgrove J., Dahl-Jorgensen K., Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatric Diabetes 2009 10 supplement 12 195 203 2-s2.0-70350148877 10.1111/j.1399-5448.2009.00576.x
27. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996 98 4 649 658 2-s2.0-0029800129
28. Jago R., Harrell J. S., McMurray R. G., Edelstein S., El Ghormli L., Bassin S., Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006 117 6 2065 2073 2-s2.0-33745290074 10.1542/peds.2005-1716 (Pubitemid 46071252)
29. Lurbe E., Alvarez V., Redon J., Obesity, body fat distribution, and ambulatory blood pressure in children and adolescents. Journal of Clinical Hypertension 2001 3 6 362 367 2-s2.0-0035207420 (Pubitemid 33138490)
30. Broe R., Rasmussen M. L., Frydkjaer-Olsen U., Olsen B. S., Mortensen H. B., Peto T., Grauslund J., The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: the Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetologica 2013 10.1007/s00592-013-0527-1
31. Gallego P. H., Craig M. E., Hing S., Donaghue K. C., Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. British Medical Journal 2008 337, article a918 2-s2.0-50649092283 10.1136/bmj.a918
32. El Asrar M. A., Adly A. A., El Hadidy E. S., Abdelwahab M. A., D-dimer levels in type 1 and type 2 diabetic children and adolescents; Relation to microvascular complications and dyslipidemia 'own data and review'. Pediatric Endocrinology Reviews 2012 9 3 657 668
33. Zieske A. W., Malcom G. T., Strong J. P., Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatric Pathology and Molecular Medicine 2002 21 2 213 237 2-s2.0-0036213913 10.1080/15227950252852104 (Pubitemid 34289953)
34. Seth A., Sharma R., Childhood obesity. Indian Journal of Pediatrics 2013 80 4 309 317
35. Sinha R., Fisch G., Teague B., Tamborlane W. V., Banyas B., Allen K., Savoye M., Rieger V., Taksali S., Barbetta G., Sherwin R. S., Caprio S., Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. The New England Journal of Medicine 2002 346 11 802 810 2-s2.0-0037076025 10.1056/NEJMoa012578 (Pubitemid 34984653)
36. Pang C., Jia L., Jiang S., Liu W., Hou X., Zuo Y., Gu H., Bao Y., Wu Q., Xiang K., Gao X., Jia W., Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes/Metabolism Research and Reviews 2012 28 3 276 283 2-s2.0-84858127605 10.1002/dmrr.1307
37. Minuto N., Emmanuele V., Vannati M., Russo C., Rebora C., Panarello S., Pistorio A., Lorini R., d'Annunzio G., Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging. Journal of Endocrinological Investigation 2012 35 4 389 394
38. Mayer-Davis E. J., Davis C., Saadine J., Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study. Diabetic Medicine 2012 29 9 1148 1152 10.1111/j.1464-5491.2012.03591.x
39. Diabetes Control Complications Trial Research Group, Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000 23 8 1084 1091
40. Kostraba J. N., Dorman J. S., Orchard T. J., Becker D. J., Ohki Y., Ellis D., Doft B. H., Lobes L. A., LaPorte R. E., Drash A. L., Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989 12 10 686 693 2-s2.0-0024468363 (Pubitemid 19284091)
41. Donaghue K. C., Fairchild J. M., Craig M. E., Chan A. K., Hing S., Cutler L. R., Howard N. J., Silink M., Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 2003 26 4 1224 1229 2-s2.0-0043169590 10.2337/diacare.26.4.1224 (Pubitemid 36929276)
42. Olsen B. S., Sjølie A. K., Hougaard P., Johannesen J., Marinelli K., Jacobsen B. B., Mortensen H. B., The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. Journal of Diabetes and Its Complications 2004 18 3 160 164 2-s2.0-2442447371 10.1016/S1056-8727(03)00073-4 (Pubitemid 38622544)
43. Harvey J. N., The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy. Diabetologia 2011 54 8 1943 1945 2-s2.0-79960898037 10.1007/s00125-011-2185-6
44. Aiello L. P., Cahill M. T., Wong J. S., Systemic considerations in the management of diabetic retinopathy. American Journal of Ophthalmology 2001 132 5 760 776 2-s2.0-0034754723 10.1016/S0002-9394(01)01124-2 (Pubitemid 33031293)
45. Stratton I. M., Kohner E. M., Aldington S. J., Turner R. C., Holman R. R., Manley S. E., Matthews D. R., UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001 44 2 156 163 2-s2.0-0035134120 10.1007/s001250051594 (Pubitemid 32156199)
46. Mühlhauser I., Cigarette smoking and diabetes: an update. Diabetic Medicine 1994 11 4 336 343 (Pubitemid 24196057)
47. Singh R., Barden A., Mori T., Beilin L., Advanced glycation end-products: a review. Diabetologia 2001 44 2 129 146 2-s2.0-0035135246 10.1007/ s001250051591 (Pubitemid 32156196)
48. Bierhaus A., Hofmann M. A., Ziegler R., Nawroth P. P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 1998 37 3 586 600 2-s2.0-0032029363 10.1016/S0008-6363(97)00233-2 (Pubitemid 28231153)
49. Raczyńska K., Zorena K., Myśliwska J., Myśliwiec M., Raczyńska-Woźniak D., Balcerska A., Analysis of the pro-angiogenic factor influencing the development of retinopathy in children with diabetes mellitus type 1. Polish Journal of Environmental Studies 2008 17 1A 132 136
50. Goldberg R. B., Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3171 3182 2-s2.0-69949093803 10.1210/jc.2008-2534
51. Zorena K., Malinowska E., Raczyńska D., Myśliwiec M., Raczyńska K., Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus. Journal of Diabetes Research 2013 2013 6 10.1155/2013/614908 614908
52. Habeeb N. M., Youssef O. I., Saab A. A., El Hadidi E. S., Adiponectin as a marker of complications in type I diabetes. Indian Pediatrics 2012 49 4 277 280
53. Toda N., Nakanishi-Toda M., Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Progress in Retinal and Eye Research 2007 26 3 205 238 2-s2.0-33947703167 10.1016/j.preteyeres.2007.01.004 (Pubitemid 46498800)
54. Santilli F., Cipollone F., Mezzetti A., Chiarelli F., The role of nitric oxide in the development of diabetic angiopathy. Hormone and Metabolic Research 2004 36 5 319 335 2-s2.0-2542533734 10.1055/s-2004-814489 (Pubitemid 38703794)
55. Wiltshire E. J., Gent R., Hirte C., Pena A., Thomas D. W., Couper J. J., Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002 51 7 2282 2286 2-s2.0-0036300151 (Pubitemid 34729036)
56. Widlansky M. E., Gokce N., Keaney J. F. Jr., Vita J. A., The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology 2003 42 7 1149 1160 2-s2.0-0141504305 10.1016/S0735-1097(03)00994-X (Pubitemid 37188333)
57. Miyamoto K., Khosrof S., Bursell S.-E., Rohan R., Murata T., Clermont A. C., Aiello L. P., Ogura Y., Adamis A. P., Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America 1999 96 19 10836 10841 2-s2.0-0032863021 10.1073/pnas.96.19.10836 (Pubitemid 29442230)
58. Pang I.-H., Yorio T., Ocular actions of endothelins. Proceedings of the Society for Experimental Biology and Medicine 1997 215 1 21 34 2-s2.0-0030946006 (Pubitemid 27194677)
59. Feng D., Bursell S.-E., Clermont A. C., Lipinska I., Aiello L. P., Laffel L., King G. L., Tofler G. H., von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care 2000 23 11 1694 1698 2-s2.0-0033765431
60. Laursen J. V., Hoffmann S. S., Green A., Nybo M., Sjølie A. K., Grauslund J., Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients. Current Eye Research 2013 38 1 174 179
61. Kern T. S., Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental Diabetes Research 2007 2007 14 95103 10.1155/2007/95103 2-s2.0-41149099068
62. Gustavsson C., Agardh C.-D., Agardh E., Profile of intraocular tumour necrosis factor- and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmologica 2013 91 5 445 452 2-s2.0-84859922095 10.1111/j.1755-3768.2012.02430.x
63. Palenski T. L., Sorenson C. M., Sheibani N., Inflammatory cytokine-specific alterations in retinal endothelial cell function. Microvascular Research 2013 89 57 69
64. Kowluru R. A., Odenbach S., Role of interleukin-1 β in the pathogenesis of diabetic retinopathy. British Journal of Ophthalmology 2004 88 10 1343 1347 2-s2.0-4744347272 10.1136/bjo.2003.038133 (Pubitemid 39312984)
65. Gordon P. A., Effects of diabetes on the vascular system: current research evidence and best practice recommendations. Journal of Vascular Nursing 2004 22 1 2 11 2-s2.0-1442335462 10.1016/S1062-0303(03)00083-9 (Pubitemid 38281159)
66. Salomaa V., Matei C., Aleksic N., Sansores-Garcia L., Folsom A. R., Juneja H., Park E., Wu K. K., Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease: the ARIC study. Atherosclerosis risk in communities. Atherosclerosis 2001 157 2 309 314 2-s2.0-0034900836 10.1016/S0021-9150(00)00729-2 (Pubitemid 32710009)
67. Asakawa H., Tokunaga K., Kawakami F., Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. Journal of Diabetes and Its Complications 2000 14 3 121 126 2-s2.0-0033832185 10.1016/S1056-8727(00)00075-1
68. Morales A., Wasserfall C., Brusko T., Carter C., Schatz D., Silverstein J., Ellis T., Atkinson M., Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 2004 27 8 2010 2014 2-s2.0-3343013826 10.2337/diacare.27.8.2010 (Pubitemid 38989247)
69. Celi F., Bini V., Papi F., Santilli E., Castellani M. S., Ferretti A., Mencacci M., Berioli M. G., De Giorgi G., Falorni A., Circulating adipocytokines in non-diabetic and type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabetic Medicine 2006 23 6 660 665 2-s2.0-33744816248 10.1111/j.1464-5491.2006.01823.x (Pubitemid 43830068)
70. Zietz B., Buechler C., Kobouch K., Neumeier M., Schölmerich J., Scäffler A., Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Experimental and Clinical Endocrinology and Diabetes 2008 116 9 532 536 2-s2.0-56049121492 10.1055/s-2008-1058086
71. Hadjadj S., Aubert R., Fumeron F., Pean F., Tichet J., Roussel R., Marre M., Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005 48 6 1088 1092 2-s2.0-21344457216 10.1007/s00125-005-1747-x (Pubitemid 40909643)
72. Kurtenbach A., Langrova H., Zrenner E., Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Investigative Ophthalmology and Visual Science 2000 41 10 3234 3241 2-s2.0-0033827750
73. Fortune B., Schneck M. E., Adams A. J., Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Investigative Ophthalmology and Visual Science 1999 40 11 2638 2651 2-s2.0-0032833358 (Pubitemid 29455495)
74. Han Y., Bearse M. A. Jr., Schneck M. E., Barez S., Jacobsen C. H., Adams A. J., Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Investigative Ophthalmology and Visual Science 2004 45 3 948 954 2-s2.0-1542637021 10.1167/iovs.03-1101 (Pubitemid 38868397)
75. Lakhani E., Wright T., Abdolell M., Westall C., Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes. Investigative Ophthalmology and Visual Science 2010 51 10 5297 5303 2-s2.0-77958138779 10.1167/iovs.10-5200
76. Lobefalo L., Verrotti A., Mastropasqua L., Loggia G. D., Cherubini V., Morgese G., Gallenga P. E., Chiarelli F., Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy. Diabetes Care 1998 21 11 2003 2006 2-s2.0-0031755009 10.2337/diacare.21.11.2003 (Pubitemid 28478308)
77. Urban B., Bakunowicz-Lazarczyk A., Peczyńska J., Urban M., The evaluation of contrast sensitivity in children and adolescents with insulin-dependent diabetes mellitus. Klinika Oczna 1999 101 2 111 114 2-s2.0-0032619671
78. Sultan M. B., Starita C., Huang K., Epidemiology, risk factors and management of paediatric diabetic retinopathy. British Journal of Ophthalmology 2012 96 3 312 317 2-s2.0-84857114722 10.1136/bjophthalmol-2011-300169
79. Maguire A., Chan A., Cusumano J., Hing S., Craig M., Silink M., Howard N., Donaghue K., The case for biennial retinopathy screening in children and adolescents. Diabetes Care 2005 28 3 509 513 (Pubitemid 40315305)
80. Rosenberg J. B., Friedman I. B., Gurland J. E., Compliance with screening guidelines for diabetic retinopathy in a large academic children's hospital in the Bronx. Journal of Diabetes and Its Complications 2011 25 4 222 226 2-s2.0-79959978852 10.1016/j.jdiacomp.2010.11.001
81. Forlenza G. P., Stewart M. W., Diabetic retinopathy in children. Pediatric Endocrinology Reviews 2012-2013 10 2 217 226
82. Hutchinson A., McIntosh A., Peters J., O'Keeffe C., Khunti K., Baker R., Booth A., Effectiveness of screening and monitoring tests for diabetic retinopathy-a systematic review. Diabetic Medicine 2000 17 7 495 506 2-s2.0-0033848553 10.1046/j.1464-5491.2000.00250.x (Pubitemid 30660150)
83. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991 98 5, supplement 786 806
84. Ahmed J., Ward T. P., Bursell S.-E., Aiello L. M., Cavallerano J. D., Vigersky R. A., The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 2006 29 10 2205 2209 2-s2.0-33845421715 10.2337/dc06-0295 (Pubitemid 44899853)
85. Scanlon P. H., Malhotra R., Thomas G., Foyt C., Kirkpatrick J. N., Lewis-Barned N., Harney B., Aldington S. J., The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetic Medicine 2003 20 6 467 474 2-s2.0-0038460765 10.1046/j.1464-5491.2003.00954.x (Pubitemid 36776007)
86. Silva P. S., Cavallerano J. D., Sun J. K., Noble J., Aiello L. M., Aiello L. P., Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. American Journal of Ophthalmology 2012 154 3 549 559
87. Ciulla T. A., Amador A. G., Zinman B., Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003 26 9 2653 2664 2-s2.0-0041358796 10.2337/diacare.26.9.2653 (Pubitemid 37055447)
88. Salardi S., Rubbi F., Puglioli R., Brancaleoni A., Bacchi-Reggiani L., Ragni L., Cacciari E., Diabetic retinopathy in childhood: long-term follow-up by fluorescein angiography beginning in the first months of disease. Journal of Pediatric Endocrinology and Metabolism 2001 14 5 507 515 2-s2.0-0035023175 (Pubitemid 32479528)
89. Doors M., Berendschot T. T. J. M., de Brabander J., Webers C. A. B., Nuijts R. M. M. A., Value of optical coherence tomography for anterior segment surgery. Journal of Cataract and Refractive Surgery 2010 36 7 1213 1229 2-s2.0-77953653090 10.1016/j.jcrs.2010.05.002
90. Hee M. R., Puliafito C. A., Duker J. S., Reichel E., Coker J. G., Wilkins J. R., Schuman J. S., Swanson E. A., Fujimoto J. G., Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998 105 2 360 370 2-s2.0-0031952382 10.1016/S0161-6420(98)93601-6 (Pubitemid 28090845)
91. Polito A., Del Borrello M., Isola M., Zemella N., Bandello F., Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Archives of Ophthalmology 2005 123 10 1330 1337 2-s2.0-26444608689 10.1001/archopht.123.10.1330 (Pubitemid 41429732)
92. Zhou D., Wei W.-B., Liu Y., Tian B., Wang D.-S., Zhao M., Clinical investigation of the Heidelberg retina tomograph II in asessment of macular edema. Chinese Journal of Ophthalmology 2008 44 10 892 898 2-s2.0-57649128474
93. Early worsening of diabetic retinopathy in the diabetes control and complications trial. Archives of Ophthalmology 1998 116 7 874 886
94. Nahata L., Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections. Clinical Pediatrics 2006 45 6 503 508 2-s2.0-33747504706 10.1177/ 0009922806290565 (Pubitemid 44257163)
95. Pańkowska E., Błazik M., Dziechciarz P., Szypowska A., Szajewska H., Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatric Diabetes 2009 10 1 52 58 2-s2.0-59149106775 10.1111/j.1399-5448.2008.00440.x
96. St Charles M., Lynch P., Graham C., Minshall M. E., A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party us payer perspective. Value in Health 2009 12 5 674 686 2-s2.0-67649958298 10.1111/j.1524-4733.2008. 00478.x
97. Neubauer A. S., Ulbig M. W., Laser treatment in diabetic retinopathy. Ophthalmologica 2007 221 2 95 102 2-s2.0-33947508712 10.1159/000098254 (Pubitemid 46465434)
98. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Archives of Ophthalmology 1995 113 9 1144 1155
99. Pareja-Ríos A., Serrano-García M. A., Marrero-Saavedra M. D., Abraldes-López V. M., Reyes-Rodríguez M. A., Cabrera-López F., López-Gálvez M., Cardona-Guerra P., Abreu-Reyes P., Quijada-Fumero E., Coronado-Toural A., Gutiérrez- Sánchez E., Gil-Hernández M. A., Valls-Quintana P., Marín-Olmos F., Navarro-Alemany R., Guidelines of clinical practice of the SERV (Spanish Retina and Vitreous Society): management of ocular complications of diabetes. Diabetic retinopathy and macular oedema. Archivos de la Sociedad Española de Oftalmología 2009 84 9 429 450 2-s2.0-75649112652
100. Maeshima K., Utsugi-Sutoh N., Otani T., Kishi S., Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 2004 24 4 507 511 2-s2.0-4043051036 10.1097/00006982-200408000-00002 (Pubitemid 39079874)
101. Polkinghorne P. J., Uliss A. I., Hamilton A. M. P., Macular oedema and retinal neovascularisation in juvenile diabetics. International Ophthalmology 1992 16 3 133 137 2-s2.0-0026767584 10.1007/BF00916431
102. Maeshima K., Utsugi-Sutoh N., Otani T., Kishi S., Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 2004 24 4 507 511 2-s2.0-4043051036 10.1097/00006982-200408000-00002 (Pubitemid 39079874)
103. Ma Y., Zhang Y., Zhao T., Jiang Y.-R., Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab. American Journal of Ophthalmology 2012 153 2 307 313 2-s2.0-84856006425 10.1016/j.ajo.2011.08.006
104. Nepomuceno A. B., Takaki E., Paes de Almeida F. P., Peroni R., Cardillo J. A., Siqueira R. C., Scott I. U., Messias A., Jorge R., A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema. American Journal of Ophthalmology 2013 156 3 502 510
105. Evoy K. E., Abel S. R., Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema. Annals of Pharmacotherapy 2013 47 6 811 818
106. Massin P., Bandello F., Garweg J. G., Hansen L. L., Harding S. P., Larsen M., Mitchell P., Sharp D., Wolf-Schnurrbusch U. E. K., Gekkieva M., Weichselberger A., Wolf S., Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010 33 11 2399 2405 2-s2.0-79251606719 10.2337/dc10-0493
107. Mitchell P., Bandello F., Schmidt-Erfurth U., Lang G. E., Massin P., Schlingemann R. O., Sutter F., Simader C., Burian G., Gerstner O., Weichselberger A., The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011 118 4 615 625 2-s2.0-79953311138 10.1016/j.ophtha.2011.01.031
108. Mitchell P., Wong T. Y., Management paradigms for diabetic macular edema. American Journal of Ophthalmology 2013 10.1016/j.ajo.2013.11.012
109. Do D. V., Nguyen Q. D., Boyer D., Schmidt-Erfurth U., Brown D. M., Vitti R., Berliner A. J., Gao B., Zeitz O., Ruckert R., Schmelter T., Sandbrink R., Heier J. S., One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 2012 119 8 1658 1665 2-s2.0-84859937024 10.1016/j.ophtha.2012.02.010
110. Mizuno S., Nishiwaki A., Morita H., Miyake T., Ogura Y., Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina. Investigative Ophthalmology and Visual Science 2007 48 6 2831 2836 2-s2.0-34347217097 10.1167/iovs.06-1041 (Pubitemid 351261240)
111. Sohn H. J., Han D. H., Kim I. T., Oh I. K., Kim K. H., Lee D. Y., Nam D. H., Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. American Journal of Ophthalmology 2011 152 4 686 694 2-s2.0-80053322513 10.1016/j.ajo.2011.03.033
112. Quiram P. A., Gonzales C. R., Schwartz S. D., Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide. American Journal of Ophthalmology 2006 141 3 580 582 2-s2.0-33144463314 10.1016/j.ajo.2005.10.004 (Pubitemid 43265976)
113. Bandello F., Polito A., Pognuz D. R., Monaco P., Dimastrogiovanni A., Paissios J., Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Archives of Ophthalmology 2006 124 5 643 650 2-s2.0-33646486870
114. Kim J. E., Pollack J. S., Miller D. G., Mittra R. A., Spaide R. F., ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema. Retina 2008 28 5 735 740 2-s2.0-43249106823 10.1097/IAE.0b013e318163194c (Pubitemid 351655127)
115. Schwartz S. G., Flynn H. W. Jr., Fluocinolone acetonide implantable device for diabetic retinopathy. Current Pharmaceutical Biotechnology 2011 12 3 347 351 2-s2.0-79551679900 10.2174/138920111794480651
116. Safety and tolerability study of the helical intravitreal triamcinolone implant in diabetic macular edema (STRIDE). 2009, http://clinicaltrials.gov/ct2/ show/NCT00915837
117. Sanford M., Fluocinolone acetonide intravitreal implant (Iluvien): in diabetic macular oedema. Drugs 2013 73 2 187 193
118. Haller J. A., Kuppermann B. D., Blumenkranz M. S., Williams G. A., Weinberg D. V., Chou C., Whitcup S. M., Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Archives of Ophthalmology 2010 128 3 289 296 2-s2.0-77749330682 10.1001/archophthalmol.2010.21
119. Verisome product information, http://iconbioscience.com/
120. Haghjou N., Soheilian M., Abdekhodaie M. J., Sustained release intraocular drug delivery devices for treatment of uveitis. Journal of Ophthalmic & Vision Research 2011 6 4 317 329
121. Klein R., Klein B. E. K., Wang Q., Moss S. E., Irvine A., Taylor H., Drews R., Crawford J. B., Schwartz A., Green W. R., Anderson W. B., The epidemiology of epiretinal membranes. Transactions of the American Ophthalmological Society 1994 92 403 430 2-s2.0-0028661147
122. Stalmans P., Benz M. S., Gandorfer A., Kampik A., Girach A., Pakola S., Haller J. A., Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. The New England Journal of Medicine 2012 367 7 606 615
123. Hikichi T., Takahashi M., Trempe C. L., Schepens C. L., Relationship between premacular cortical vitreous defects and idiopathic premacular fibrosis. Retina 1995 15 5 413 416 2-s2.0-0028785551
124. Kim J. H., Kang S. W., Ha H. S., Kim J. R., Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema. Korean Journal of Ophthalmology 2013 27 3 186 193